Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Elucidating the effect of interleukin-7 signaling on T cell receptor signaling
FY 2013-14
Summary
T cells are crucial components of the immune system, and interleukin-7 (IL-7) is a soluble protein that plays a key role in regulating normal T cell behaviour. Previous studies have linked defects in the expression of the IL-7 receptor to T cell malfunctions in various conditions, namely human immunodeficiency virus (HIV) infection, some cases of breast cancer, and multiple sclerosis. The molecular mechanisms involved in these situations are still unknown - but before understanding what is broken in disease, we should first determine what is supposed to happen in health. Since the activation of the T cell receptor (TCR) is arguably the most important event in normal T cell activation and in normal T cell function in general, this project's goal will be to determine the effect of IL-7 cellular signaling on TCR signaling, and to identify which IL-7 signaling pathway is responsible for this effect.
Experiments will require isolating T cells from informed, consenting healthy donors' blood. Four different cell populations will be isolated using commercially available products: naïve T cells (which have never been activated by a microbe; their TCR has never been stimulated), and memory T cells (which are long-lasting cells that have previously reacted to a microbe, have had their TCR stimulated, and are now ready to respond quickly to a re-infection by their microbe), from both CD4+ and CD8+ T cell populations (which play different roles in the immune system and are differentiated by proteins on their cell surface). Once these cell populations are isolated, they will be treated with purified IL-7 and/or with beads that stimulate the TCR, and the effect of these treatments on cell signaling pathways will be measured. Two different methods commonly used in molecular biology - Western blots and flow cytometry - will be used to detect if key molecules in TCR-triggered signaling pathways have been activated by the treatments. Cells will also be treated with drugs that individually inhibit the different cell signaling events activated by IL-7, in order to determine which of these pathways might play a role in affecting TCR signaling.
Gaining a better understanding of how T cells are normally affected by IL-7 and TCR stimulation will lay down the groundwork to determining how these normal processes are affected in various disease states. This may in turn eventually create new leads to find new treatments for patients living with HIV, some types of cancer, or multiple sclerosis.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311856
Name
Cousineau Sophie E
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the effect of interleukin-7 signaling on T cell receptor signaling
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Basic Research; Interleukin-7; Primary Human T Cells; T Cell Dysregulation; T Cell Receptor Signaling
Abstract
T cells are crucial components of the immune system, and interleukin-7 (IL-7) is a soluble protein that plays a key role in regulating normal T cell behaviour. Previous studies have linked defects in the expression of the IL-7 receptor to T cell malfunctions in various conditions, namely human immunodeficiency virus (HIV) infection, some cases of breast cancer, and multiple sclerosis. The molecular mechanisms involved in these situations are still unknown - but before understanding what is broken in disease, we should first determine what is supposed to happen in health. Since the activation of the T cell receptor (TCR) is arguably the most important event in normal T cell activation and in normal T cell function in general, this project's goal will be to determine the effect of IL-7 cellular signaling on TCR signaling, and to identify which IL-7 signaling pathway is responsible for this effect.
Experiments will require isolating T cells from informed, consenting healthy donors' blood. Four different cell populations will be isolated using commercially available products: naïve T cells (which have never been activated by a microbe; their TCR has never been stimulated), and memory T cells (which are long-lasting cells that have previously reacted to a microbe, have had their TCR stimulated, and are now ready to respond quickly to a re-infection by their microbe), from both CD4+ and CD8+ T cell populations (which play different roles in the immune system and are differentiated by proteins on their cell surface). Once these cell populations are isolated, they will be treated with purified IL-7 and/or with beads that stimulate the TCR, and the effect of these treatments on cell signaling pathways will be measured. Two different methods commonly used in molecular biology - Western blots and flow cytometry - will be used to detect if key molecules in TCR-triggered signaling pathways have been activated by the treatments. Cells will also be treated with drugs that individually inhibit the different cell signaling events activated by IL-7, in order to determine which of these pathways might play a role in affecting TCR signaling.
Gaining a better understanding of how T cells are normally affected by IL-7 and TCR stimulation will lay down the groundwork to determining how these normal processes are affected in various disease states. This may in turn eventually create new leads to find new treatments for patients living with HIV, some types of cancer, or multiple sclerosis.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cousineau, Sophie E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~